The signaling axis CDK12-BRCA1 mediates dinaciclib associated radiosensitivity through p53-mediated cellular senescence.
N. Garcia-Flores, D. M. Fernandez-Aroca, C. Garnes Garcia, A. Dominguez-Calvo, s. sabater, I. Andres, J. Jimenez Suarez, P. Fernandez-Aroca, F. J. Cimas, G. de Carcer, B. Belandia, I. Palmero, P. Huertas, M. j. Ruiz-Hidalgo, R. Sanchez-Prieto
This paper shows dinaciclib increases radiosensitivity in some cancer cell lines by inhibiting CDK12, reducing BRCA1, and promoting p53-dependent senescence.
bioRxiv · Apr 25, 2024 · PreprintCancer Biology